Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Respiratory Syncytial Virus (RSV) L-protein is a large, multifunctional enzyme essential for the replication and transcription of the RSV genome. It acts as the viral RNA-dependent RNA polymerase (RdRp) and is responsible for several enzymatic activities required for viral RNA synthesis, including mRNA capping and methylation. The L-protein is considered an attractive antiviral drug target, and inhibitors targeting this protein have shown broad-spectrum activity against both major subtypes A & B. Resistance mutations often map to its capping enzyme domain.
Inhibition of RNA-dependent RNA polymerase activity, inhibition of capping enzyme activity, inhibition of methyltransferase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory Syncytial Virus L-protein.